Ethinamate

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of ethinamate
General
Non-proprietary name Ethinamate
other names

(1-ethynylcyclohexyl) carbamate

Molecular formula C 9 H 13 NO 2
External identifiers / databases
CAS number 126-52-3
EC number 204-789-4
ECHA InfoCard 100.004.355
PubChem 3284
DrugBank DB01031
Wikidata Q410225
Drug information
Drug class

Hypnotic

properties
Molar mass 167.21 g mol −1
Physical state

firmly

Melting point

96 ° C

safety instructions
GHS labeling of hazardous substances
07 - Warning

Caution

H and P phrases H: 302
P: no P-phrases
Toxicological data
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Ethinamate is a drug with short-term sedating and hypnotic effects that has been used to treat insomnia . Regular use leads to tolerance ; the effects usually last no longer than seven days. Ethinamate was patented for Schering in 1957 as a sedative and sleeping aid . It is no longer in trade worldwide.

Presentation and extraction

The synthesis starts from cyclohexanone , which is reacted with ethyne and sodium in liquid ammonia . The carbamate function is then introduced on the resulting 1-ethynylcyclohexanol by reaction with phosgene and ammonia.

Ethinamate synthesis01.svg

Legal status

In the Federal Republic of Germany, ethinamate is a marketable narcotic drug , but not a prescription drug, according to Annex II to Section 1 Paragraph 1 of the Narcotics Act. Possession without permission from the Federal Opium Agency at the Federal Institute for Drugs and Medical Devices is a criminal offense.

Individual evidence

  1. Entry on ethinamate in the DrugBank of the University of Alberta .
  2. a b Ethinamate data sheet from Sigma-Aldrich , accessed on October 22, 2016 ( PDF ).
  3. ^ A b c d e f g A. Kleemann , J. Engel, B. Kutscher, D. Reichert: Pharmaceutical Substances - Synthesis, Patents, Applications , 4th edition (2001) Thieme-Verlag Stuttgart, ISBN 978-1-58890 -031-9 .
  4. a b Patent US 2,816,910 (Schering 1957).
  5. Narcotics Act 1981, Annex II, as of December 25, 2012.